Toxic myopathies

Joint Bone Spine

Volumn 80, Issue 3, 2013, Pages 231-233

  Guis, Sandrine ^a   Mattei, Jean Pierre ^a   Bendahan, David ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; CHLOROQUINE; CITALOPRAM; CLEVUDINE; CLOZAPINE; COLCHICINE; CYCLOSPORIN; DIGOXIN; DILTIAZEM; FLUINDOSTATIN; FLUOXETINE; FLUVOXAMINE MALEATE; HYDROXYCHLOROQUINE; IMATINIB; IMIDAZOLE; MACROLIDE; MEVINOLIN; MIBEFRADIL; OLANZAPINE; OMEPRAZOLE; PAROXETINE; PRAVASTATIN; QUETIAPINE; RISPERIDONE; SERTRALINE; SIMVASTATIN; UNINDEXED DRUG; WARFARIN; ZIDOVUDINE; TOXIN; VENOM;

ADVERSE OUTCOME; ALCOHOL CONSUMPTION; CLINICAL FEATURE; DRUG SAFETY; EDITORIAL; ETHNICITY; FATIGUE; GENE MUTATION; HUMAN; MUSCLE BIOPSY; MUSCLE CRAMP; MUSCLE FATIGUE; MUSCLE SPASM; MYALGIA; RHABDOMYOLYSIS; SEX DIFFERENCE; TOXIC MYOPATHY; VITAMIN D DEFICIENCY; CHEMICALLY INDUCED; MUSCLE DISEASE; PATHOPHYSIOLOGY; TOXICITY;

HUMANS; MUSCULAR DISEASES; MYALGIA; TOXINS, BIOLOGICAL; VENOMS;

EID: 84878349423     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.10.008     Document Type: Editorial

References (14)

1. Kushlaf H.A. Emerging toxic neuropathies and myopathies. Neurol Clin 2011, 29:679-687.
2. Mastaglia F.L., Needham M. Update on toxic myopathies. Curr Neurol Neurosci Rep 2012, 12:54-61.
3. Guis S., Krahn M., Fernandez C., Mattei J.P., Levy N., Bendahan D. Pathologies des muscles striés squelettiques. EMC - Appareil Locomoteur 2010, 1-19. [Article 15-143-A-10].
4. Guis S., Mattei J.P., Lioté F. Drug-induced and toxic myopathies. Best Pract Res Clin Rheumatol 2003, 17:877-907.
5. Dalakas M.C. Toxic and drug-induced myopathies. J Neurol Neurosurg Psychiatry 2009, 80:832-838.
6. Guis S., Mattei J.P., Cozzone P.J., et al. Pathophysiology and clinical presentations of rhabdomyolysis. Joint Bone Spine 2005, 72:382-391.
7. Smiley I.W., Khan B.V., Sperling L.S. Management of the statin-intolerant patient. Curr Treat Options Cardiovasc Med 2009, 11:26-71.
8. Joy T.R., Hegele R.A. Narrative review: statin-related myopathy. Ann Intern Med 2009, 150:858-868.
9. Link E., Parish S., Armitage J., et al. SLCO1B1 variants and statin-induced myopathy: a genome wide study. N Engl J Med 2008, 359:789-799.
10. Seok J.I., Lee D.K., Lee C.H., et al. Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA. Hepatology 2009, 49:2080-2086.
11. Kilbourne E.M., Rigau-Perez J.G., Heath C.W., et al. Clinical epidemiology of toxic oil syndrome: manifestations of a new illness. N Engl J Med 1983, 309:1408-1414.
12. Bedry R., Baudrimont I., Deffieux G., et al. Wild mushroom intoxication as a cause of rhabdomyolysis. N Engl J Med 2001, 345:798-802.
13. Matsuura M., Saikawa Y., Inui K., et al. Identification of the toxic trigger in mushroom poisoning. Nat Chem Biol 2009, 5:465-467.
14. Prasad G.V., Wong T., Meliton G., et al. Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation 2002, 74:1200-1201.